Myocardial salvage after reperfusion may be limited by deleterious vascular changes in the previously ischemnic microcirculatory bed. This could result in a progressive decrease in blood flow in the capillary bed to potentially viable myocytes (no-reflow phenomenon). The effect of intracoronary adenosine on these changes was assessed in 15 closed-chest dogs subjected to 2 hours of proximal left anterior descending artery (LAD) occlusion followed by 3 hours of reperfusion. Animals randomly received adenosine (n=8) 3.75 mg/min into the proximal LAD or an equivalent volume of saline (control) (n=7) for 1 hour after reperfusion. Endothelialdependent and independent coronary vasodilator reserve was determined using a chronically implanted volume-flowmeter on the mid-LAD at baseline and 1 and 3 hours after reperfusion with acetylcholine and papaverine infusions, respectively, into the proximal vessel. Regional myocardial blood flow was measured serially with radioactive microspheres and regional contractile function with contrast ventriculography. Both agonists produced a significant increase in LAD flow before occlusion. Endothelial-dependent and independent vasodilatory reserve was significantly reduced (p<0.05) at 1 and 3 hours after reperfusion in control animals compared with adenosine treatment. A progressive decrease in mid-LAD flow and increase in coronary vascular resistance after reperfusion was observed in control animals (p<0.05). The treated group manifested improved regional myocardial blood flow in endocardial regions from the central (0.73±+0.15 versus 0.24±0.11 ml/g/min; p<0.02) and lateral ischemic zones (0.80±0.15 versus 0.34±+0.12 ml/g/min; p<0.O5) 3 hours after reperfusion. A significant reduction (p<0.05) in endocardial and midmyocardial flow compared with baseline was seen in control animals at 3 hours. Intravascular and interstitial neutrophil infiltration was reduced in adenosine animals and this was associated with relative ultrastructural preservation of endothelial cells. Regional ventricular function in the ischemic zone was improved in the adenosine group 3 hours after reperfusion (13.4±3.9% versus -5.3±1.6%; p<0.001). This study demonstrates that selective administration of adenosine after reperfusion significantly attenuates functional and structural abnormalities hi the microvasculature after prolonged (2 hours) regional ischemia in the canine model. Prevention of microvascular injury and the no-reflow phenomenon by adenosine may preserve reversibly injured myocytes following restoration of blood flow to previously ischemic myocardium. (Circulation 1989;80:1388-1399 T imely reperfusion either pharmacologically, mechanically, or surgically has been demonstrated to have beneficial effects on infarct size and ventricular function in experimental models and in humans.1-6 However, the restoration of blood flow to the previously ischemic but reversibly injured endothelial and myocardial cells has been
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Experimental Preparation
Mongrel dogs of both sexes weighing 20-30 kg were quarantined for 2 weeks before study to ensure they were free of canine diseases. One week before the experiment, the animals were anesthetized with intravenous sodium pentobarbital (30 buried in a subcutaneous pocket in the subscapular region. Prophylactic antibiotics were administered, and the dogs were allowed 5-7 days to recover before experimental use.
Experimental Protocol
On the day of the experiment, the dogs were randomized to either intracoronary adenosine infusion or control (intracoronary saline infusion) (Figure 1 Louis, Missouri) was dissolved in normal saline to form a solution of 2.5 mg adenosine/ml NaCI. Animals randomized to the adenosine group received 3.75 mg/min intracoronary infusion through the distal tip of the infusion wire into the proximal LAD. The volume administered was 1.5 ml/min over a 60-minute period for a total volume of 90 ml (225 mg adenosine). The estimated plasma concentration of adenosine in the LAD, assuming a flow of 50 ml/min and hematocrit of 40%, was 0.12 mg/min. Control animals received the same volume of saline into the proximal LAD. Regional myocardial blood flow was subsequently obtained 10-15 minutes after initiation of adenosine therapy, at 1 hour into reperfusion before discontinuation of the adenosine infusion, and at 3 hours after reperfusion. Coronary vasodilatory reserve was repeated 1 hour and 3 hours after reperfusion. After obtaining a ventriculogram, the left thorax was opened and the LAD snare ligated under direct vision. Monastral blue dye (DuPont) was injected through a pigtail catheter positioned in the ascending aorta in a dose of 1 mg/kg, 2-3 minutes after ligating the snare. After administration of 20-40 meq potassium chloride, the hearts were rapidly excised and washed to prevent counterstaining. The area at risk was measured by computerized planimetry as previously described. 28 
Coronary Vascular Reactivity
Pilot studies were performed in three animals to determine the dose of each vasodilator that produced maximal vasodilation. Doses of acetylcholine from 5 to 30 gug/min and papaverine 2-8 mg/min were administered by either a 5-minute infusion through a Harvard constant-infusion pump or bolus injection. Infusion rates of 15 ,g/min acetylcholine and 4 mg/min papaverine were the lowest doses to produce maximal response in these animals.
Endothelial-dependent and -independent vascular reactivity were evaluated by selective infusion of acetylcholine (15 jig/min) and papaverine 4 The hearts were cut into 1-cm transverse sections parallel to the atrioventricular groove from apex to base. The third transverse slice was sectioned into three zones: central ischemic (middle of risk region), lateral ischemic (zone immediately adjacent to central region and entirely within risk region), and nonischemic posterior wall. Each zone was further subdivided into epicardial, midmyocardial, and endocardial sections weighing 0.3-1.0 g. Myocardial sections and reference blood samples were counted for 5 minutes in a multichannel analyzer (Model 5986, Packard Instrument, Downers Grove, Illinois) with background correction and the overlapping radioactivity between isotopes corrected using matrix correction method (Compusphere Software, Packard Instrument).28
Light Microscopy
The second slice from all hearts was fixed in 10% buffered formaldehyde. After 3 days of fixation, sections were cut for light microscopy from the ischemic area (region of infarction), the two border zones (lateral), and the posterior wall (nonischemic area), extending from endocardium to epicardium, from eight randomly selected cases (four each from control and adenosine groups). Tissue was dehydrated and embedded in paraffin; sections were cut and stained with hematoxylin and eosin and examined by light microscopy in a blinded manner. Myocardial biopsy samples were taken within 60 seconds of death from the central ischemic zone (anterior wall) and the nonischemic zone (posterior wall) and divided into endocardial and epicardial halves. The tissue was cut in 1-mm3 pieces and fixed in 3% buffered glutaraldehyde for transmission electron microscopy. Thirty-two specimens were examined from eight (four adenosine-treated and four control) randomly selected animals. Tissue was allowed to fix for 1-6 hours and then transferred to 1% osmium tetraoxide in 0.1 M cacodylate buffer, dehydrated, and embedded in epon. Semithin sections were cut, stained with toluidine blue, and examined by light microscopy. The artifact-free areas with the most capillaries were selected for ultrathin section cutting, stained with uranyl acetate lead citrate, and examined with Zeiss 109 IGF electron microscope.
Statistics
Serial results in the groups (i.e., blood pressure, heart rate, myocardial blood flow) were analyzed by repeated measures, two-way analysis of variance. If there was a statistical difference found between some pair of results, then further pairwise analysis was performed by two-tailed t test. Comparisons between the two groups (i.e., vascular reactivity) were analyzed by nonpaired Student's t test with two-tailed discriminant score.
Results
Twenty-six dogs underwent randomization. Eleven animals (six control and five adenosinetreated) died at occlusion from intractable ventricular fibrillation. The remaining 15 animals (eight adenosine and seven control) form the basis for this report. Two of these animals (one adenosinetreated and one control) were successfully resuscitated from occlusion ventricular tachycardia and completed the experimental protocol.
Hemodynamic Variables
No significant differences were observed in heart rate, systolic or mean blood pressure (data not shown), or rate-pressure product (Figure 2 Regional Myocardial Blood Flow Results of regional myocardial blood flow in all animals is illustrated in Figure 3 . Baseline flows were significantly higher in the endocardial and midmyocardial sections of the central and lateral ischemic zones in control animals. Both groups of animals demonstrated severe subendocardial ischemia in the central and lateral ischemic zones consistent with comparable poor collateral blood flow to these regions. Endocardial flow in the central ischemic zone was 0.05±0.01 and 0.09±0.04 ml/min/g in control and adenosine animals, respectively (p=NS). This was confirmed by measurement of area at risk, which was similar in adenosine and control animals (38.9+4.7% versus 35.4± 5.1%). Selective administration of adenosine at 3.75 mg/ min during the first hour of reperfusion resulted in an increase in blood flow in all three zones, which reached statistical significance in the epicardium. An increase in flow in the nonischemic segments (posterior wall) was also noted with adenosine infusion possibly related to recirculation through Figure 7 . Note relative preservation of vascular reactivity in the adenosine animal.
Regional Ventricular Function
Percent radial shortening in the ischemic zone at baseline, 1 hour into occlusion, and 3 hours after reperfusion is illustrated in Figure 8 . Light and Electron Microscopy Light microscopy revealed marked differences in neutrophil accumulation within the ischemic myocardium between the two groups ( Figure 9 ). Control animals demonstrated an average of 1.5+ neutrophils in the interstitial and intravascular spaces, whereas adenosine animals had 0.25 and 0.75 neutrophil accumulation, respectively. Contractionband formation was also more prominent in the control than in adenosine-treated animals.
Electron microscopy of the endocardial ischemic regions in both control and adenosine-treated animals showed changes of irreversible and reversible ischemic injury. Irreversible changes included peripheral margination of nuclear chromatin and shrunken nuclei, disruption of sarcolemmal membranes, and bleb formation; and mitochondrial changes of clearing of matrix, fragmentation of cristae, and presence of amorphous matrix densities. These changes of irreversible injury were more extensive in control animals, whereas reversible changes of ischemia, which include mitochondrial swelling, loss of normal dense mitochondrial matrix, and absence of amorphous and granular flocculent densities, were more prominent in adenosine dogs.
Moderate to severe capillary changes were observed in the ischemic region in control dogs ( Figure 9A-C) . These included endothelial swelling, decreased pinocytotic vesicles, membrane-bound vesicles, and swollen endothelial protrusions. The latter, in association with neutrophils, platelets, fibrin, and stacked red cells, resulted in partial or total obstruction of capillary lumens. Endothelial disruption was rarely seen. Adenosine-treated animals had less endothelial swelling and infrequent membrane-bound vesicles and endothelial protrusions. None of the adenosine animals showed neutrophil plugging of capillaries, although occasional platelets and fibrin strands were seen entrapped in mild endothelial protrusions ( Figure 9D-F) . Capillary disruption was absent in all adenosine-treated animals. Capillaries in the nonischemic myocardium of control and adenosine-treated animals were intact with occasional endothelial folds, and the myocardium showed no changes of reversible or irreversible ischemia.
Discussion Present Study
This study demonstrates that selective administration of the potent coronary arteriolar vasodilator adenosine at 3.75 mg/min for 1 hour after reperfusion significantly preserved endothelial-dependent and independent vasodilatory reserve in a closedchest canine model subjected to prolonged regional ischemia (2 hours). Control animals manifested a progressive decrease in endocardial and midmyocardial blood flow in the ischemic zone commencing 10-15 minutes after reperfusion suggestive of the no-reflow phenomenon. In contrast, myocardial blood flow was maintained in adenosine-treated animals and was similar to baseline values 3 hours after reperfusion. Ultrastructural analysis showed extensive microvascular injury in the capillaries of the ischemic subendocardium associated with luminal plugging by endothelial cell protrusions, neutrophils, platelets, and red cells in control animals. In contrast, these changes were attenuated after adenosine treatment with relative preservation of endothelial cells and only occasional obstruction of capillaries by cellular elements. Regional myocardial contractile dysfunction remained severely depressed in the control group 3 hours after reperfusion, with all animals manifesting dyskinesis. Adenosine treatment resulted in a marked improvement in regional ventricular function, with the development of positive shortening in the ischemic zone. This study and the previous observation in our laboratory that adenosine significantly reduces infarct size after 90 minutes of ischemia highlights the importance of microvascular injury and the no-reflow phenomenon in attenuating salvage of potentially viable myocytes in areas of prior ischemia (reperfusion injury).26 Selective adenosine infusion after prolonged regional ischemia reduced structural and functional injury in the reperfused vascular bed, thereby preventing the progressive fall in regional blood flow and enhanced regional contractile function of viable myocytes.
Mechanisms of Vascular Injury
The exact pathogenesis of vascular injury during ischemia and reperfusion remains speculative. We have previously demonstrated that administration of the perfluorochemical (Fluosol-DA), a potent antineutrophil agent, prevented structural and functional endothelial damage 1 hour after reperfusion.31,32 Neutrophils could produce lethal injury to potentially viable cells by releasing numerous potent proteolytic enzymes, myeloperioxidase, and reactive oxygen species.12-15 Although a burst of free radicals has been shown to occur soon after reperfusion in the intact animal, studies using numerous free radical scavenging agents have failed to show consistent effects on myocardial reperfusion injury.11,33-39Although one study suggests that superoxide dismutase and catalase reduced ultrastructural changes in the endocardial region after reperfusion, the effects of these agents on vascular responses have not been investigated. 40 This study and previous studies from our laboratory demonstrate that reperfusion results in accelerated structural changes in the capillaries of the previously ischemic bed. 26 The exact mechanism for the striking vascular protection achieved by exogenous adenosine in this study remains to be clarified. Adenosine modulates the effects of various cellular elements that may be involved in the pathogenesis of reperfusion injury. Adenosine could enhance the functional recovery of endothelial cells by restoring the metabolic machinery of the cell either through replenishment of ATP stores or by enhanced oxygen delivery to the microvasculature due to arteriolar dilatation.20 '21 Mechanical obstruction of capillary channels by neutrophils may be reduced by vasodilation, inhibition of platelet aggregation and thromboxane release, reduction in neutrophil adherence to endothelial cells, or all these processes.20,23,24 Adenosine may also reduce neutrophil-mediated cellular damage by inhibiting release of reactive oxygen species from activated inflammatory cells.22 Continued functional viability of endothelial cells due to adenosine therapy would allow maintenance of microcirculatory flow with oxygenated hemoglobin. This hypothesis is supported by the observation that pretreatment with 5-amino-4-imidazole carboxamide-riboside (AICAriboside), a substance that augments adenosine release from energy-deprived cells, significantly improved regional myocardial blood flow after 60 minutes of ischemia in the dog. 48 Effect ofAdenosine on Postischemic Ventricular
Contractile Function
The significant improvement in regional ventricular function noted in treated animals suggests that adenosine attenuated the prolonged ventricular dysfunction of viable myocytes after ischemia (stunning).49 Numerous mechanisms have been postulated for this phenomenon including depletion of ATP stores and excess production of oxygenderived free radicals during early reperfusion.35'39'50,51
The improved contractile function in this study may be related to replenishment of high energy stores by administration of supraphysiological doses of its precursor. Alternatively, adenosine may have reduced reactive oxygen production during reperfusion by reversing intramyocardial production through breakdown of purine compounds or by inhibiting release of superoxide anion from activated neutrophils. Removal 
